{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:52:53Z","timestamp":1774029173788,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute kidney injury (AKI) and anemia have been extensively studied in ST-elevation myocardial infarction (STEMI), yet the precise nature of their reciprocal relationship has not been elucidated in STEMI patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective analysis of 2096 consecutive patients admitted for STEMI between January 2008 and December 2018 and treated with primary coronary intervention. Patients were stratified into four groups according to the presence of baseline anemia and occurrence of AKI: without anemia or AKI, baseline anemia without AKI, AKI without baseline anemia and acute cardiorenal anemia syndrome (CRAS), defined as the occurrence of AKI in patients with baseline anemia. Patients\u2019 medical records were reviewed for in-hospital complications, 30-day and long-term mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean age was 61 \u00b1 13 years and 1682 patients (80%) were men. Ten percent of patients had baseline anemia without AKI, 7% had AKI without baseline anemia and 3% were classified as CRAS. We found increments between the four groups for occurrence of new onset atrial fibrillation and heart failure rates, presence of a critical state, and both 30-day and long-term mortality (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 for all). Logistic regression models demonstrated that as compared to AKI alone, CRAS was associated with a higher risk for long-term mortality (HR 10.49; 95% CI 6.5\u201317.1) as compared to anemia (HR 3.32, 95% CI 2.1\u20135.2) and AKI (HR 7.71, 95% CI 5.1\u201311.7) alone (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 for all).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Among STEMI patients, the interaction between anemia and AKI is associated with worse short and long-term outcomes and reflects the reciprocity of cardiac and renal exacerbations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000973","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T11:33:22Z","timestamp":1602761602000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Acute cardiorenal anemia syndrome among ST-elevation myocardial infarction patients treated by primary percutaneous intervention"],"prefix":"10.1097","volume":"32","author":[{"given":"Ilan","family":"Merdler","sequence":"first","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itamar","family":"Loewenstein","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zahler","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Levit","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviram","family":"Hochstadt","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Gal-Oz","sequence":"additional","affiliation":[{"name":"Nephrology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacov","family":"Shacham","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2004.03.080","article-title":"Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.","volume":"44","author":"Nikolsky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes.","volume":"111","author":"Sabatine Marc","year":"2005","journal-title":"Circulation"},{"key":"R3-20250729","first-page":"50","article-title":"Association of admission hemoglobin levels and acute kidney injury among myocardial infarction patients treated with primary percutaneous intervention.","volume":"31","author":"Shacham","year":"2015","journal-title":"Can J Cardiol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1523-1755.2005.67131.x","article-title":"Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions.","volume":"67","author":"Nikolsky","year":"2005","journal-title":"Kidney Int"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","article-title":"Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.","volume":"95","author":"Dangas","year":"2005","journal-title":"Am J Cardiol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.","volume":"35","author":"Silverberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2008.10.046","article-title":"Anemia: the point of convergence or divergence for kidney disease and heart failure?","volume":"53","author":"Kazory","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0959.1000233","article-title":"Cardio renal syndrome.","volume":"6","author":"Kulkarni","year":"2016","journal-title":"J Nephrol Ther"},{"key":"R9-20250729","first-page":"E1","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of emergency physicians and society for cardiovascular angiography and interventions.","volume":"82","author":"O\u2019Gara","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"R13-20250729","first-page":"5","article-title":"Report of a who scientific group.","volume":"405","year":"1968","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000443339","article-title":"Impact of cardiorenal anemia syndrome on short- and long-term clinical outcomes in patients hospitalized with heart failure.","volume":"6","author":"Kim","year":"2016","journal-title":"Cardiorenal Med"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2012.12.049","article-title":"Cardiorenal anemia syndrome as a prognosticator for death in heart failure.","volume":"111","author":"Lu","year":"2013","journal-title":"Am J Cardiol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.70.4.357","article-title":"Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.","volume":"70","author":"Anand","year":"1993","journal-title":"Br Heart J"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2004.05.070","article-title":"Anemia as a risk factor and therapeutic target in heart failure.","volume":"44","author":"Felker","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ki.1997.50","article-title":"Oxygen and renal metabolism.","volume":"51","author":"Epstein","year":"1997","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"R19-20250729","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ndt\/gfh1066","article-title":"Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.","volume":"20","author":"Persson","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: mechanisms, risk factors, and prevention.","volume":"33","author":"Seeliger","year":"2012","journal-title":"Eur Heart J"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1213\/00000539-199007000-00013","article-title":"Contrast media adversely affect oxyhemoglobin dissociation.","volume":"71","author":"Kim","year":"1990","journal-title":"Anesth Analg"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators.","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) study group.","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the third national health and nutrition examination survey (1988-1994).","volume":"162","author":"Astor","year":"2002","journal-title":"Arch Intern Med"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease.","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","article-title":"The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.","volume":"35","author":"Dries","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12928-020-00660-8","article-title":"Contrast-induced acute kidney injury.","volume":"35","author":"Chandiramani","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"key":"R28-20250729","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"e005715","DOI":"10.1161\/JAHA.117.005715","article-title":"Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit?","volume":"6","author":"Caspi","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.amjcard.2014.07.032","article-title":"Relation of time to coronary reperfusion and the development of acute kidney injury after ST-segment elevation myocardial infarction.","volume":"114","author":"Shacham","year":"2014","journal-title":"Am J Cardiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/clc.22215","article-title":"Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction.","volume":"37","author":"Shacham","year":"2014","journal-title":"Clin Cardiol"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40620-019-00594-2","article-title":"C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.","volume":"32","author":"Zahler","year":"2019","journal-title":"J Nephrol"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/eurheartj\/ehp070","article-title":"C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction.","volume":"30","author":"\u00d8rn","year":"2009","journal-title":"Eur Heart J"},{"key":"R34-20250729","first-page":"11","article-title":"Cardio-renal anemia syndrome.","volume":"12","author":"Efstratiadis","year":"2008","journal-title":"Hippokratia"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:08:02Z","timestamp":1753812482000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000973","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}